The purpose of this study is to determine the safety, efficacy and pharmacokinetics of OMS302 (the study drug) for maintaining intraoperative mydriasis and preventing post operative pain in individuals undergoing Intraocular Lens Replacement (ILR) surgery.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Mean Area Under the Curve Analysis of Change-from-Baseline in Pupil Diameter (mm) During Surgery
Timeframe: From surgery baseline (pre-incision) through surgery end (time of cortical clean-up/wound closure)
Mean Area Under the Curve Analysis of Ocular Pain VAS Score Within 12 Hours Postoperatively
Timeframe: 12 hours postoperatively